Walden University

ScholarWorks
Walden Dissertations and Doctoral Studies

Walden Dissertations and Doctoral Studies
Collection

2018

Association Between Body Mass Index And
Depression On Hbaic Control Among Veterans
Opokua Osei-Yeboah
Walden University

Follow this and additional works at: https://scholarworks.waldenu.edu/dissertations
Part of the Public Health Education and Promotion Commons
This Dissertation is brought to you for free and open access by the Walden Dissertations and Doctoral Studies Collection at ScholarWorks. It has been
accepted for inclusion in Walden Dissertations and Doctoral Studies by an authorized administrator of ScholarWorks. For more information, please
contact ScholarWorks@waldenu.edu.

Walden University
College of Health Sciences

This is to certify that the doctoral study by

Opokua Osei-Yeboah

has been found to be complete and satisfactory in all respects,
and that any and all revisions required by
the review committee have been made.

Review Committee
Dr. Egondu Onyejekwe, Committee Chairperson, Public Health Faculty
Dr. Xianbin Li, Committee Member, Public Health Faculty
Dr. Donna Clews, University Reviewer, Public Health Faculty

Chief Academic Officer
Eric Riedel, Ph.D.

Walden University
2018

Abstract
Association Between Body Mass Index and Depression on HBA1C Control Among
Veterans
by
Opokua Osei-Yeboah

MSN, St Xavier University, 2012
BSN, Framingham State University, 2006

Doctoral Study Submitted in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Public Health
Public Health

Walden University
November 2018

Abstract
The study investigated the association between body mass index (BMI) and depression
based upon glycated hemoglobin levels (HBA1C) among United States veterans. Based
on Bandura’s social cognitive theory, a cross-sectional analysis examined the association
between BMI and depression on HBA1C regulation, and if the interaction between BMI
and depression affects HBAIC regulation among veterans. Multiple regression analysis
was used to test the multivariate associations between depression and BMI on the
outcome variable of HBA1C. Linearity, normality, and homoscedasticity were assessed
using normal probability plots and residual analysis. Durbin-Watson statistics were used
to test for autocorrelations, and variance inflation factor was used to check for
multicollinearity. There was not a statistically significant difference between those who
were depressed (Mdn = 32.76, IQR = 7.8) and those who were not depressed (Mdn =
33.27, IQR = 5.0) in terms of BMI (U = 774.0, p = 0.47). When depression, BMI, an
interaction term for depression*BMI, and other predictor variables were entered into the
regression model, these variables did not account for a significant increase in shared
variance in A1C (ΔR2 = 0.17, F (14, 74) = 0.17, p = 0.37). Social change implications
generated from this study include better resource utilization, improved quality of care,
increased veteran satisfaction and improved veteran experience across the healthcare
system. The findings from the study can be used to expand access to specialized services
for chronically ill veterans, coordinate resources, better outcomes and facilitate seamless
care coordination between mental health and primary care providers.

Association Between Body Mass Index and Depression on HbA1C Control
Among Veterans
by
Opokua Osei-Yeboah

MSN, Saint Xavier University, 2012
BSN, Framingham State University, 2006

Doctoral Study Submitted in Partial Fulfillment
of the Requirements for the Degree of
Doctor of Public Health
Public Health

Walden University
November 2018

Dedication
I dedicate my research to my dear husband, Fred Osei-Yeboah and my four lads,
Jared Bernard Addo, Kwesi Yeboah, Kwabena Osei-Yeboah, and Kofi Osei-Yeboah. To
my siblings, Akosua McDonald and Nyantakyiwa Buotu for your encouragement, during
the times I wanted to quit you encouraged me to press on, letting me know I can
accomplish this goal. Also to my aging parents, Benjamin and Matilda Asare Buotu, both
of whom have been waiting to see me graduate, through the emotional ups and downs,
you assured me to rely my strength onto God, for he will see me through and he did! This
journey was accomplished with the support and encouragement from all of you. I owe
this accomplishment to all of you from the bottom of my heart.

Acknowledgments
The journey to this great accomplishment seemed never-ending, with mixed
feelings on how to survive the stress of school. Many days I felt like this was not
achievable due to the amount of commitment needed to balance school, family life, and
work. But I know God’s ways are the best, and his plans for us never fail. The very first
thank you goes to God Almighty. With God all things are possible, and without his
protection, this milestone would have been impossible to complete. The book of
Philippians 4:13 says “I can do all things through Christ who strengthens me.” May his
name be glorified? I give him all the thanks, praise, and adoration.
Second, I salute my husband Mr. Fred Osei-Yeboah who is my number fan, I
wouldn’t have made it without his help and support. His words always echoed “you are
almost at the end you can do this!” Balancing four active boys who are involved in sports
could not have been more challenging. However, my husband stepped in and ensured
things get done promptly.
Third, my dissertation committee chair, Dr. Egondu Onyejekwe, for sharing her
knowledge and expertise in helping me narrow my research question and guiding me
through each step. Dr. Xiaban Li, first committee chair member, for reviewing the data
analysis multiple times to ensure accuracy, Dr. Donna Clews, University Research
Reviewer for her guidance, Dr. Tammy Root, Academic Research Coordinator for her
support, and Dr. Rea, Program Director for words of encouragement. Also, to Dr.
Howard Gordon at the Department of Veterans Affairs for being a mentor and helping me

obtain the study database. Finally, to Pastor Pokoo at Lifetouch Worship Center, for his
prayers and kind words of encouragement throughout the school year.

Table of Contents
Table of Contents ........................................................................................................... i
List of Tables ............................................................................................................... iv
List of Figures ......................................................................................................................v
Section 1: Foundation of the Study and Literature Review .................................................1
Introduction ....................................................................................................................1
Problem Statement .........................................................................................................4
Purpose of the Study ......................................................................................................6
Nature of the Study ........................................................................................................7
Research Questions and Hypothesis ..............................................................................7
Theoretical Framework ..................................................................................................8
Operational Definitions ..................................................................................................9
Assumptions.................................................................................................................11
Limitations ...................................................................................................................11
Scope and Delimitations ..............................................................................................12
The Significance of the Study ......................................................................................12
Social Change Contribution .........................................................................................13
Summary and Transition ..............................................................................................13
Review of Literature ....................................................................................................15
Health Care pending. ............................................................................................ 15
Obesity and Obesity-Related Health Outcomes ................................................... 15
i

Obesity .................................................................................................................. 18
Diabetes Mellitus (DM) ........................................................................................ 19
Veterans and the Prevalence of Diabetes .............................................................. 22
Summary of Literature review .....................................................................................26
Section 2: Research Design and Data Collection ..............................................................29
Introduction ..................................................................................................................29
Power and Sample Size ................................................................................................30
Protection of Human Subjects and Participant Information ........................................32
Research Design and Strategy .....................................................................................32
Protection of Participant rights ....................................................................................33
Setting and Sample ......................................................................................................34
Data Analysis ...............................................................................................................37
Statistical Methods .......................................................................................................37
Section 3: Presentation of the Results and Findings ..........................................................38
Introduction ..................................................................................................................38
Results of Research Question 1 ...................................................................................38
Results of Research Question 2 ...................................................................................39
Summary ......................................................................................................................44
Section 4: Application to Professional Practice and Implications for Social Cha45nge
Introduction ..................................................................................................................45
Interpretation ................................................................................................................47
ii

Recommendations ........................................................................................................49
Implications for Future Research .................................................................................51
Social Change Implications .........................................................................................52
Conclusions ..................................................................................................................53
References ..........................................................................................................................55

iii

List of Tables
Table 1. Obesity………………………………………………………….………............16
Table 2. Research Questions/Study Variables……………………...................................30
Table 3. A Priori Sample Calculation…………………………….………………...........31
Table 4. Demographic Characteristics……………………………………………….…. 36
Table 5. Descriptives of Research Question 1….............................................................. 39
Table 6. Model Summary Research Question 2….……………………………...……....40
Table 7. Regression Coefficients…...……………………………….….………..............41

iv

List of Figures
Figure 1. Histogram...........................................................................................................42
Figure 2. Normal P-plot of regression standardized residual............................................43
Figure 3. Scatterplot …………………………………………………………………….44

v

1
Section 1: Foundation of the Study and Literature Review
Introduction
According to a detailed report by the American diabetes association (ADA),
diabetes mellitus (DM) (2018) is listed to be the seventh leading cause of death in the
United States (U.S.) with a significant impact on health outcomes. According to Rowley,
Bezold & Krohe (2017), the projected prevalence of DM in the U.S has reached alarming
proportions with an expected projection that number will rise by 54% of the U.S.
population to greater than 54.9 million people by the year 2030. The total cost to treat the
population diagnosed with diabetes in the year 2012 was $245 billion, that figure
however, had risen to 327 billion in 2017 of which $237 billion originated from direct
medical costs and the other 90 billion, from reduced productivity (ADA, 2018).
Tuomilehto et al. (2001) stated, diabetes pathogenesis is characterized by genetic
susceptibility along with modifiable behavior and environmental risk factors such as
obesity and sedentary lifestyles. My review of extant literature produced several
epidemiologic studies that supported the active role of physical activity and how it can
avert obesity and diabetes mellitus type II (DM type II). Hu (2003), found that some of
the primary reasons known to drive the prevalence of DM type II are obesity and inactive
lifestyles, such as many hours spent watching television and poor dietary habits.
Obesity is listed as one of the critical public health concerns; a significant risk factor for
diabetes, high blood pressure, and heart disease (Pi-Sunyer, 2009).
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A body mass index (BMI) of higher than 30kg/m2, defines obesity. BMI is used
to calculate an individual’s weight in proportion to height to confirm the presence of
excess body fat and to determine if a person is obese, overweight or underweight (Flegal
& Graubard, 2009). As a result, BMI is recognized to be an essential measurement that
identifies patients who are susceptible to poor health outcomes which result from obesity
(Djalalinia, Qorbani, Peykari, & Kelishadi, 2015) Worldwide, obesity claims about three
million lives annually, poses a significand health burden, drives health care expenditure,
impacts quality of life and causes multiple chronic health problems (Djalalinia et. al
2015). In further support of the role obesity plays to the diabetic epidemic, (Hurt,
Kulisek, Buchanan, and McClave (2010) reported that obesity is a huge medical
challenge for providers with severe comorbidities, economic and health repercussions.
Similarly, (Djalalinia et al. 2015) publicized that obesity drives serious health
repercussions, is burdensome to healthcare systems, and is a critical risk factor for
metabolic disorders, especially DM II, a focus of this doctoral study.
Andreoulakis, Hyphantis, Kandylis, & Iacovides (2012), reported people who
have been diagnosed with diabetes are at increased risk for persistent or recurrent
depression. When depression and diabetes co-occur health outcomes and or quality of life
are significantly impacted, clinical deterioration persists and mortality is increased.
One of the critical symptoms of major depression is a decreased interest in doing things,
fatigued loss of energy, appetite changes and in some cases, individuals become suicidal
and or commit suicide (Badescu et al., 2016). Depressed patients who suffer from DM
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type II clinically present with poor blood sugar control, poor eating habits, decreased
physical activity due to fatigue, poor self-management therefore the risk of diabetes
related complications are heightened (Badescu et al., 2016). This overwhelming evidence
warrants an understanding of the pathophysiology of DM type II, the crucial role of
obesity, and how individuals manage diabetes in the wake of depression. With this
knowledge, appropriate strategies can be implemented to control this epidemic and
improve the health of the population (Schafer, Machicao, Fritsche, & Haring, 2011).
Among veteran’s, diabetes is listed as the third most prevalent diagnosis,
consuming an enormous amount of healthcare resources (Reiber, Koepsell, Maynard,
Haas, & Boyko, 2004). In 2011, the Veterans Affairs (VA) primary care clinics across the
nation reported 24.4% of their veterans had diagnosed diabetes, 52.3% hypertension, and
another 36.6% were diagnosed with obesity (Cully et al., 2014). Over the years, obesity
has been established as the Number 1 risk factor to diabetes with supporting evidence
from the ADA (2014) showing that being obese predisposes an individual to some level
of insulin resistance. Even though, a significant proportion of DM type II patients are
obese which has contributed to the growing incidence and prevalence rates of diabetes
over the last two decades (Ecke, Robert, Kahn, Steven, & Smith, 2011). Conversely,
depression is a common comorbidity noted among persons who suffer from chronic
conditions, and this added burden makes it difficult for patients to manage and or perform
self-care activities for better health (Berge, Rilse, Tell, Iverson, Ostbye, Lund & Knudsen
2015; Vogelzangs, Kritchevsky, Beekman, Brenes, Newman, Satterfield, Penninx 2010).
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In this doctoral study, I aimed to gain an understanding of the unique association between
BMI and depression on a veteran’s ability to control diabetes. Using the results from this
study, I will make recommendations to place particular emphasis on resource utilization
that will improve care coordination between mental health practitioners and primary care
providers to better the health of veteran’s.
Problem Statement
The VA is known as one of the largest healthcare organizations in the country and
operates approximately 1,240 facilities nationwide with services to over nine million
veterans (Veterans Health Administration, 2018). In a review of several veteran medical
records Olenick, Flowers, and Diaz (2015) indicated that one in three veterans suffer
from at least one mental health disorder. Other veteran’s often suffer from substance
abuse disorders, traumatic brain injuries, chronic pain, and homelessness. According to
Kinsinger (2015), the VA health system has witnessed a considerable number of veterans
who bear a high burden of chronic diseases. Out of about 6 million veterans that used
primary care services in 2011, 36.7% were obese, 52.3% had high blood pressure, 24.4%
were diabetic, 16.1% had ischemic heart disease, and another 8.4% has a chronic
obstructive pulmonary disease (Kinsinger, 2015). These figures stand higher among
veterans than the national averages of the U.S. population (Kinsinger, 2015).
With this knowledge, it is evident that the VA health system faces significant
healthcare challenges including extensive resource utilization and the quest to improve
poor outcomes which stem from chronic diseases (Del Re, Maciejewski, & Harris, 2013).
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Franklin, Rajan, Tseng, and Sinha (2014) disclosed that one in four veterans suffers from
diabetes which places a significant burden on the healthcare costs of the VA and
dramatically reduces the quality of life for the veterans. Regarding obesity, the office of
Research and Development (2016), a research branch of the VA, reported about 165,000
veterans have a BMI of greater than 40. The National Institute of Health (NIH, 2017) has
specific classifications for BMI, where a person with a BMI of between 18.5 and 25 is
considered healthy, 25 to 29.9 overweight, 30 to 39.9 obese, and > 40 extremely obese or
morbid obesity; a dangerous health condition (NIH, 2017; U.S Department of VA, Office
of Research & Development (R&D), 2016).
Obesity and severe obesity puts a person at very high risk for diabetes
hypertension and cardiovascular disease (NIH, 2017). The obesity epidemic is
particularly concerning among veteran’s post deployment because weight gain is known
to be evident (Breland et.al 2017). The obesity pattern has also been witnessed as
veterans grow older, and this is especially significant because veterans contribute to the
considerable portion of the population of the United States (Maguen et al., 2013). When
an individual harbors DM type II, the beta cells cannot secrete enough insulin to
counterbalance insulin resistance, and insulin resistance is known to derive from
environmental determinants including obesity (Schafer et al., 2011).
Various research studies have improved our understanding of the association
between obesity and depression, arriving at similar conclusions that possession of
multiple chronic conditions contribute to disabling health (Vogelzangs et al., 2010).
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Several studies (Bajaj, Agarwal, Varma. & Singh 2012; Berge and Riise 2015 and Fiore
et al. 2015) confirmed that the association between diabetes and depression produces
adverse and debilitating effects; consequently, a person may experience a more inferior
quality of life because of poor self-care practices and medication noncompliance. De la
Cruz-Cano et al. (2015) studied the association between obesity and depression in
patients with DM II with a focus on determining whether being obese increased an
individual’s risk for depression in the setting of DM type II. Despite established
information detailing that the combination of depression, obesity, and diabetes produces
poor health outcomes, my review of the literature produced limited cross-sectional
studies that had examined the association between obesity and depression on glycemic
control among veterans.
Purpose of the Study
In this study, I investigated the association between BMI and depression to
determine whether this association affects HBA1C regulation among veterans with DM
type II diabetes using a sample of veterans from the VA healthcare system. The study
results will perfect our current understanding of the complexity of managing multiple
chronic illnesses and to better understand whether the relationship between BMI and
depression contribute to uncontrolled diabetes among veterans. By understanding this
association, multidisciplinary collaboration, and care interventions can be coordinated to
achieve improvements in target health outcomes, improve quality of life and decrease
excessive healthcare spending within the Veterans Health Administration.
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Nature of the Study
The study was quantitative, with secondary data analysis. A cross-sectional design
with review of electronic medical records was utilized. To confirm the presence of
depression, I will review the veteran’s medical records for the results of a positive or
negative Patient Health Questioanaie-2 (PHQ-2) screen: a measure of depressive
symptoms and anhedonia over a 2 week period (NIH, 2017). In this study, I will discuss
HBAIC, a serum blood level that serves as a measure of blood sugar regulation over a
3month period, BMI and weight. I hypothesized that a veteran with a BMI > 30 and a
HBA1C > 7.5 is depressed, and therefore, unable to regulate their diabetes.
Research Questions and Hypothesis
I developed the following research questions and hypotheses to guide this study:
RQ1: Is there an association between BMI and depression among veterans?
H01: There is no association between BMI and depression.
H11: There is an association between BMI and depression.
RQ2: Does the interaction between BMI and depression predict HBA1C
regulation among veterans?
H02: The interaction between BMI and depression does not predict
HBA1C regulation among veterans
H12: The interaction between BMI and depression predicts HBA1C
regulation among veterans.
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Theoretical Framework
Diabetes management requires the patient to maintain a healthy diet, control their
weight, adhere to their medication, engage in physical activity, monitor blood glucose,
reduce stress, and keep regular medical appointments (Adejoh, 2016). Being able to
perform the actions mentioned in the preceding sentence remains a challenge for
diagnosed individuals because it requires a change in their behavior. According to Green
(2000) human behavior is complex because human behavior can be influenced by the
environment. Both the environment and human behavior are determinants of an
individual’s health, and changing individual or group behavior can be challenging
(Green, 2000). For change to be active and sustained, researchers have proposed various
health theories as well as social and behavioral sciences to understand the questions why,
what, and how. Theories are useful in predicting health behavior and to effectively
arrange and appraise interventions (Green, 2000).
The theoretical framework that I selected for this study was the social cognitive
theory (SCT), an epistemological work of Albert Bandura (1986). The SCT details that
the way in which humans behave can be envisioned based on reciprocal and dynamic
influence of personal factors, behavior and environment (Bandura, 1986). According to
Bandura, personal elements, environmental conditions, behavior, and cognition all
operate together reciprocally as factors affecting each other in opposite directions. SCT
emphasizes three key factors that affect the probability that an individual would change
their health behavior: self-efficacy, goals, and outcome expectancies (Bandura, 1986).
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When a person possesses a sense of personal control over a health behavior, they are
optimistic to change, even amidst barriers (Bandura, 1986). SCT has three critical facets
of utmost relevance: the development of skills through skilled exemplars, the
empowerment of individual beliefs in their ability to promote the use of talent, and the
improvement self-motivation through target systems (Bandura, 1989).
The concept of self-efficacy beliefs serves as a crucial factor which can
contribute or impede an individual’s motivation, actions, and affect (Bandura, 1988,
1989). The cognitive process of self-efficacy beliefs iterates when an individual possesses
a solid self-efficacy, they are more apt to set higher goals for themselves and are more
likely to ensure goal attainment (Bandura 1988). For this study, the concept of selfefficacy enabled me to understand how a person’s perception of their self-efficacy can
influence their self-worth and induce their motivation to participate in various health
activities (Bandura, 1988, 1989).
Operational Definitions
Body mass index (BMI): According to the NIH Heart Lung and Blood Institute
(DATE), BMI, including waist circumference, is used to screen and confirm the
diagnosis of overweight/obesity; a severe medical condition. NIH (2017) furthers stated
that in the adult population, a BMI between 18.5 and 25 is considered healthy, 25 to 29.9
overweight, 30 to 39 obese, and > 40 extremely obese. Evidence confirmed that high
body fat poses a risk for metabolic diseases, especially DM type II and high cholesterol,
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and a majority of patients with diabetes are either overweight or obese (Bays, Chapman,
& Grady, 2007).
Depression: According to The NIH (2017, depression is relatively prevalent
significant mood disorder that affects an individual’s thought process diagnosed based on
persistent symptoms for a minimum of 2 weeks (NIH, 2017). Depression causes severe
symptoms that interfere with feelings, thoughts, work, sleep, eating patterns, and the
ability to manage activities of daily living.
Hemoglobin A1C (HBA1C): A blood test that fundamentally discloses the
average blood sugar level over a three-month period used to diagnose DM type II. The
HBA1C standards are used by providers to track and monitor how patients control
diabetes. With the HBA1C, providers ensure patients meet treatment goals and
medications are adjusted per the HBA1C level so that diabetes-related complications are
reduced (NIH, 2017). The NIH categorizes A1C in three different levels. Normal
HBA1C is rated below the level of 5.7%; however, with consistent levels above 6.5%, an
individual stands the risk of being diagnosed with diabetes (NIH, 2017). A1C levels of 8
or higher generate an estimated blood glucose levels of > 180 subsequently known to
produce adverse complications which include effect mood swings and poor sleep (Czech,
Orsillo, Pirraglia, English, & Connell, 2015).
Veteran: According to Title 38 of the Code of Federal Regulations, a veteran is an
individual that served in the active military, U.S. Navy, or U.S. Air Force and other
military branches and was released or discharged honorably (VA, 2016)
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Assumptions
In this study, I used the dataset gathered to investigate the association between
BMI and depression on HBA1C levels. Using a cross-sectional survey design and based
on the research questions, I made the following assumptions:
•

Depression alters a veteran’s ability to manage their diabetes.

•

Overweight veterans are depressed, and therefore, unable to control their
diabetes.

•

Elevated BMI and depression do not affect a veteran’s blood sugar level.

•

Veterans do not understand the importance of weight management and blood
sugar control.
Limitations

I identified a few limitations. First, I conducted the study among the veteran
population, so the results can only be generalized to veterans and not to the general
population. The second limitation was the use of convenient sampling from a database of
diabetic veterans at one particular VA hospital in an urban area. Another limitation was
the use of cross-sectional survey design. The use of cross sectional study design allows
me to perform a quick and cost effective analysis, and to evaluate more than one
outcome. Some of the limitations are the fact that data gathered on the study participants,
are recorded one time, therefore association may be deduced but causation cannot be
established (Sedgwick, 2014).
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Scope and Delimitations
In this study, I drew on secondary datasets of the veteran diabetic population. The
database was made available from the VA Office of R&D. The focus of this study was to
understand the association between BMI and depression and whether this association
affects blood glucose regulation. Other diseases that resulted from military service were
excluded.
The Significance of the Study
One of the crucial risk factors for diabetes is obesity (Pi-Sunyer, 2009).
Depression is also a common comorbidity noted among persons who suffer from chronic
conditions (Berge et al., 2015; Vogelzangs et al., 2010). Among the veteran population,
nearly one in four has diabetes which, therefore, places a significant burden on healthcare
costs and quality of life (Franklin et al., 2014). According to the National Center for
Veterans Analysis and Statistics (2015), about 92% of veterans are men with a median
age of 65 years. The growing population of veterans is estimated at over 20 million, and
are known to seek healthcare services from other healthcare agencies outside of the VA
(National Center for Veterans Analysis and Statistics, 2015). The predominantly male
population of veterans becomes particularly important when looking at various health
issues and other economic equations because there is that probability that sex difference
are exaggerated.
It is imperative to understand that the United States veteran population is a
unique population with a variety of wartime service eras from the Vietnam War to
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Operation Iraqi Freedom. This variety of veterans based on their period of service
presents healthcare providers with specific health issues. However, mental health seems
to be the most common diagnosis with 1 out of every 3 veterans possessing a mental
health disorder, most often depression (Olenick et al., 2015). In this study, I aimed to gain
an understanding of the unique association between BMI and depression on a veteran’s
ability to control diabetes. What I learn from this study can be used to place particular
emphasis on resource utilization and improve care coordination for veterans to achieve
glycemic goals.
Social Change Contribution
The results of this study will impact social change positively concerning veterans’
health because when the health of the veteran population is improved, there can be the
potential reduction in other health factors such as high blood pressure, cardiovascular
disease, hypocholesteremia, and some forms of cancer. When their health is improved,
their health outcomes are ultimately enhanced and the economic costs are decreased in
the VA healthcare system (De la Cruz-Cano et al., 2015; Green, Branchi, & Albright,
2012). Also, the VA organization will reap cost-saving benefits when health care reform
is pushing for integrated primary care with a team of providers working together to
manage the unique needs of patients.
Summary and Transition
Diabetes is the fundamental cause of mortality and morbidity in the nation.
According to Marx (2013), in 2007, the cost to treat diabetes was estimated at $174
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billion and that figure has since increased to $245 billion by 2012. These prices include a
loss of productivity and healthcare resource utilization. Over decades, diagnosed diabetes
prevalence has risen among the U.S. population from 3.5% in 1990 to 7.9% in 2008,
before remaining steady between the years 2008–2012 (Curtis, Kothari, Paul, & Connors,
2013). The yearly rates of diabetes is on the rise, especially among adults who harbor
about 95% of Type 2 diabetic cases (Curtis et, al. 2013; Marx, 2013).
Given the obesity rates of veterans as well as the high prevalence of diabetes,
there is a concern for their poor health outcomes, which led to this study focusing on
providers who work with veterans to develop successful strategies. Developing
successful strategies to reduce diabetes prevalence in this study included identifying
veterans who are a high risk of obesity, veterans with depressive symptoms, and veterans
who demonstrate the inability to regulate their A1C and making the appropriate referrals.
The results from this study provide a valuable contribution that extends the understanding
of how to create successful interventions to include collaborative effort between primary
care and mental health practitioners to better the health of veterans.
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Review of Literature
For this study, I conducted a thorough literature review. In the first subsection of
the literature review, I will address obesity and obesity-related health outcomes, while in
the second, I will discuss depression and how it affects the management of chronic
illness. The third subsection will include a discussion of diabetes and its related health
outcomes while the fourth contains the health outcomes of the veteran population and
how obesity diabetes and depression and priority areas for the VHA system. I will end the
section with a presentation of the study variables, study methodology to explore the
variables, and the gap in the literature regarding the association between BMI and
depression. Accessed through the Walden University Library, I used several databases
and search engines to search for published, peer-reviewed articles: CINAHL, Google
Scholar, PubMed, PsycINFO, Sage, OVID, Academic Premier, Science Direct, Medline,
and PubMed Central. The keywords I used for the search included obesity, depression,
diabetes, chronic illness, veteran's health, Veterans Healthcare System priority health
focus, complications of chronic diseases, patient health questionnaire tool to screen for
depression, diabetes and depression and healthcare spending.
Obesity and Obesity-Related Health Outcomes
The CDC (2017) defined BMI of 30 or higher as obese, which equates to a person
being 30 lbs. overweight. BMI is a description of the percentage of body fat concerning
weight and height (CDC, 2017). The calculation of BMI is as follows: weight
(lbs.)/height (inches) squared x 703 (CDC, 2017). In general, individuals who are obese
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stand the risk for many adverse health conditions and diseases compared to individuals
without obesity, including hypertension, DM type II, and coronary artery diseases (CDC,
2017). According to the NIH (2013), approximately 78 million adults are obese, which
signals a significant public health problem (NIH, 2013). The obesity trend further reveals
90% of people with diagnosed with diabetes are typically overweight and that number is
expected to increase (Obesity Society, 2015).
Table, 1.
Obesity
Weight

Obesity class

Underweight

BMI(kg/m2)
<18.5 -24.9

Normal

25.0-29.9

Overweight

I

30.0-34.9

Obesity

II

35.0-39.9

Extreme Obesity

III

≥ 40

According to Hurt et al. (2010), in the last three decades, the United States has witnessed
an increased incidence of obesity rates among the adult population to an alarming rate of
60%. As a result, doctors encounter significant challenges to providing healthcare
resulting in an enormous amount of healthcare resources needed to treat obesity-related
health conditions. The estimated cost to treat obesity is approximately $150 billion
annually, notwithstanding the high mortality and morbidity rates (Hurt et al., 2010).
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According to Selassie and Sinha (2011), a significant proportion of the population
in the United States is overweight, whereas a third are obese. This problem is even more
evident within developing countries and continues to grow; hence, driving the trend to
epidemic proportions as being witnessed with the subsequent massive burden on
healthcare systems (Selasie & Sinha, 2011). The authors further mentioned that the
factors contributing to the current trend are the environment; foods rich in calories;
decreased physical activity; and the availability of technology, whereby time is spent
watching television and technology used to assist with many household duties (Selassie
& Sinha, 2011). Herrera, & Lindgren (2010) argued obesity is a disease that originates
from energy variance that depicts the intake of energy is higher than the consumed;
hence, the net result is weight gain. Evidence from the last 20 to 30 years has shown that
the annual weight gain of the adult U.S population is about 0.5kg to 1 kg (Herrera &
Lindgren, 2010).
Extensive research has revealed the correlation between an individual’s risk for
obesity and genetic and biological factors. Specific genes linked to the risk of obesity
include peroxisome proliferator-activator receptor-y gene and prohormone con-vertase-1
gene (Selassie & Sinha, 2011). Of utmost relevance is the role of the environment in
obesity. In recent years, the considerable portion serving size in restaurants, beverages
with high sugar content, and high fatty foods seem to be prevalent in communities
(Selassie & Sinha, 2011). This dietary pattern and consumption of caloric dense foods
has contributed to the rise in the obesity rates (Benton, 2015; Selassie & Sinha, 2011).
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Mokdad, Ford, and Bowman (2003) publicized that obesity and diabetes are one
of the critical causes of mortality and morbidity in the United States. Mokdad et al. used
the Behavior Risk Factor Surveillance System to analyze the association between obesity
and crucial various health risk factors and revealed the significant association between
obesity, hypertension, asthma, arthritis, diabetes, high cholesterol, and poor health
conditions.
Wang, Beydon, Liang, Caballero, & Kumanyika (2008) reported obesity is
burdensome to society, notwithstanding the social, psychological, and health
consequences faced by obese individuals. Obesity impacts life expectancy and drives
healthcare costs in the billions. The CDC (2017) estimated obesity related medical
expenditures for the year 2008 at $147 billion are attributed to obesity-related medical
expenditures and that figure will continue to rise as the prevalence rates increases. The
obesity-related spending comes from both direct and indirect costs with direct costs
including preventative care, diagnostics, and treatments, all of which result in loss of
productivity due to limited activity (CDC, 2017: Wang et al., 2008). Indirect costs
involve morbidity and mortality to loss of income from premature death (Wang et al.,
2008).
Obesity
As I previously mentioned, one of the critical public health concerns in the United States
is obesity because it is a significant risk factor for diabetes, high blood pressure, and heart
disease (Pi-Sunyer, 2009, Hurtet et al., 2010). Both men and women are at risk for and

19
considered obese if they display a BMI of higher than 30kg/m2 (CDC, 2017). As a result,
BMI is known as an essential measurement to identify patients who are susceptible to
obesity-related poor health outcomes (Klien et al., 2007). According to Klien et al.
(2007), the projected obesity-related direct healthcare costs will double every 10 years,
and by 2030, the costs are estimated to be more than $950 billion, which accounts for
about 17% of average healthcare expenditure. Every year, over 300,000 deaths are caused
by obesity, a rate almost as high as cigarette smoking, which causes about 400,000 deaths
a year (Klien et al., 2007). Obesity is known to be controlled and prevented by engaging
in physical activity and changing behavior; some other ways to modify behavior to
combat obesity include improving dietary habits, being physically active, and setting
goals that are achievable to reduce weight loss (Obesity Action Coalition, 2018).
Diabetes Mellitus (DM)
The CDC (2012) defined diabetes as a disease where serum blood glucose levels
are above average. In simple terms, the human body cannot make or metabolize insulin;
therefore, sugar builds up in the bloodstream causing adverse health (CDC, 2012).
Among the Top 10 leading causes of death and disability in the United States, diabetes
ranks seventh (CDC, 2012). The American diabetes association (2018), reported over
75,00 deaths in 2015 were attributed to diabetes. This figure excludes the long-term
health damage of diabetes and costs involved to sustain life and reduced productivity
(ADA, 2018). The CDC (2007) estimated that the direct medical cost to treat diabetes
was $116 billion and another $58 billion was spent to treat diabetes-related
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complications. In the year 2010, the CDC (2012) reported individuals over 20 years of
age comprised 1.9 million of the people diagnosed with diabetes (CDC, 2012). However,
the highest number of each new case diagnosed among the population were in the age
group of 45–64 years old (CDC, 2012).
The ADA (2017) has four different classifications and diagnosis of diabetes
namely, diabetes Type 1; diabetes Type 2; other specific types such as genetic defects, a
disease of the pancreas; and gestational diabetes (ADA, 2017). Prediabetes is when a
person’s blood sugar is slightly higher than average levels, yet not high enough to be
diagnosed as diabetic (ADA, 2017). A review of the literature reveal prediabetes can
cause damage to the heart, specifically heart attack and renal system. The symptoms are
masked, with long term consequences such as heart and kidney damage, when left
untreated, prediabetes can progress to DM type II (ADA, 2017). In the prediabetes stage,
there are chances for the individual to lower their risk of diabetes when they engage in
physical activity and other weight loss initiatives that include the target of losing 7% of
their body weight (ADA, 2017).
The ADA’s (2017) first classification is known as diabetes Type 1 or insulindependent diabetes, prevalent among children and young adults. According to
researchers, Type 1 diabetes is attributed to possible environmental factors and results
from a virus that attacks the immune system causing an attack on the beta cells of the
pancreas (ADA, 2017). Therefore, the body does not make any insulin and the individual
diagnosed becomes insulin dependent (ADA, 2017; CDC, 2012). DM II accounts for
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approximately 90%–95% of diabetic cases (ADA, 2017) and affects the body’s ability to
produce enough insulin (ADA, 2017). DM II disproportionately affects African
Americans, Asian Americans, Latinos, Native Hawaiians, and other Pacific Islanders as
well as the elderly (ADA, 2017, p. 1; Office of Minority Health, 2016).
Gestational diabetes occurs around 24 weeks of gestation when the mother is
unable to make and absorb the insulin needed for the duration of the pregnancy (ADA,
2017. Overall, the risk factors to develop diabetes are age 45 or higher are strong family
history, hypertension, hypocholesteremia, an episode of gestational diabetes, physical
inactivity, and obesity (ADA, 2017). Other types of diabetes are known to originate from
pancreatic disorders and/or are drug- induced, such as taking steroids to treat other
diseases (ADA, 2017)
DM is known as one of the most complex progressive metabolic disorders,
affecting over 382 million people globally and is a known contributor to microvascular
and macrovascular diseases that affect various organs, mainly the eyes, kidneys,
cardiovascular system, and nerves (Zaccardi, Webb, Yates, & Davies, 2016). The classic
microvascular complications include damage to the retina, dysfunction of the peripheral
nerves, and kidney damage, whereas heart disease, peripheral vascular disease, and stroke
constitute microvascular complications (Zaccardi et al.). As the peripheral vascular
disease progresses, an individual becomes susceptible to non-healing wounds which can
further lead to lower extremity amputations (Deshpande, Haris-Haynes, & Shootman,
2008).
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The clinical manifestations of DM are hyperglycemia. Once diagnosed,
individuals, demonstrate the simultaneous existence of insulin resistance and B-cell
disorder due to the body’s immune activation against B-cells (Cornell, 2015; Zaccardi et
al., 2016). Other related pathophysiological processes accompanying impaired insulin is
the body's inability to respond to insulin cells hence, causing hyperglycemia. This
hyperglycemia state further results in clinical symptoms such as weight loss, weakness,
frequent urination (polyuria), and excessive thirst (Seph et al., 2015).
According to the (CDC, 2012), the rates of DM has climaxed, reaching epidemic
proportions in the United States. Similarly, there is a rise in the incidence rates of diabetic
patients who have an end-stage renal disease; the leading chronic disease caused by
diabetes. Nonetheless, the disease, DM, has many significant complications stemming
from blindness to lower extremity amputations and a major contributory factor to stroke
and heart disease. As previously mentioned, diabetes is rated the seventh leading cause of
mortality in the United States alone and afflicting over 20 million people. Each year, over
$130 billion is spent to treat diabetes-related medical conditions factored in this figure are
indirect costs from untimely death and disability (ADA, 2014; Miller & Pogach, 2008;
Selph et al., 2015).
Veterans and the Prevalence of Diabetes
Veterans are comprised of diverse background and referred to as a group with a
distinct culture. The culture whereas military engrained includes teamwork, values,
customs, identity rank, hierarchy and standards of behavior (Olenick et al 2015).
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Nonetheless, various military service and war era produces multiple experiences which
include specific health issues. For instance, Operation Endurance Freedom and Operation
Iraqi Freedom (OEF/OIF) veterans are a younger population more socially integrated
compared to veterans who served in the Vietnam Era and the Persian Gulf. Review of
literature found that, 75% of OEF/OIF population were notably obese and or overweight,
and so are faced with the equal risk of hypertension, diabetes and cardiac disease
(Maguen et al.,2013; Olenick et al, 2015).
Mental Health and Obesity
In the United States, veterans are considered a significant proportion of the adult
population an estimated population of 23.1 million as documented in the year 2009
(Koepsell et al., 2012). A review of literature from various studies reveal approximately 1
in 3 patients have a diagnosis of at least one mental health disorder. Also, there is
evidence that obesity is an epidemic among veterans as disclosed from results from
national telephone survey generated from the 1999-2008 National Health and Nutrition
Examination Survey (NHANES). This obesity epidemic has been evident mainly postdeployment because of poor dietary habits and because of aging (Kopesell et al. 2012;
Olenick et al. 2015).
In a quantitative study by Wiltink et al. (2013), the researchers mentioned that
abdominal obesity is a crucial risk factor for both cardiovascular and metabolic diseases
compared to obesity. Similarly, Koepsell, et al. (2012) referenced that veterans possess a
higher waist circumference compared to the general population. A waist circumference of
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greater than 80cm in women and more elevated than 94cm in men increases the risk of
insulin resistance (Gierach, Gierrach, Ewertowska, Arndt, & Junik, 2014).
Both depression and diabetes are known to cause a substantial burden on the
healthcare system and become burdensome for patients. An estimated 24% of patients
who have diabetes have a higher chance of developing depression. Consequently, with
the diagnosis of depression, the risk for diabetes is heightened. When patients are
depressed, self-efficacy is impacted whereby poor self-care practices is witnessed such as
dietary noncompliance, lack of exercise and poor sugar regulation is witnessed
(Gonzalez et al. 2007). With this background knowledge, there is a need for joint efforts
between mental health providers and medical providers to join efforts.
One of the most burdensome significant public health concerns is the complexity
and prevalence of depression and obesity. An estimated 10% of the United States
population suffers from depression yearly. Consequently, the obesity values have risen to
30% hence proves the magnitude of the issue as it leads to poor health outcomes such as
diabetes and heart disease (Afari et al., 2010). Review of literature revealed many studies
that examined the association between obesity, weight gain, and depression with different
conclusions. For instance, McCrea, Berger, and King (2012) in a quantitative study
examined the relationship between BMI and mental health disorders. The study reported
that BMI is associated with prevalent mental health disorders; however, the association
was known to vary with age. Similarly, Sacks-Ericsson et al. (2007) examined the
association between BMI and succeeding depressive symptoms among adults residing in
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the five counties of North Carolina over 65 years. The study concluded that BMI,
predicted depressive symptoms, more so higher among African Americans compared to
Whites.
Contrary to the findings of Sacks-Ericsson et al. (2007), a study by FormanHoffman et al., (2007) discovered in a prospective study conducted in over 9,000 people
age 53-63 that increased weight did not produce depressive symptoms. Instead, weight
loss led to increased depressive symptoms in used of unadjusted modes among men (OR
= 1.26, 95% CI = 1.04 -1.53). Increased symptoms of depression although did not predict
weight loss, predicted subsequent weight gain in men only models that were unadjusted
(OR = 1.24, 95% CI = 1.00 - 1.54) Women (OR =1.12, 95% CI = 1.00-1.26); FormanHoffman et al., 2007).
Not surprisingly a systematic review and meta-analysis conducted by De Wit et
al. (2010) in a longitudinal study, examined the association between depression and
obesity to ascertain factors that might be of influence. The researcher's confirmed a
complimentary association between depression and obesity. Obesity was noted to
increase an individual's susceptible to depression, and depression noted to be a risk factor
for obesity. The overall unadjusted OR were tabulated among 15 studies included in the
review (N = 58,745). Obesity increases the likelihood of being depressed at follow up;
unadjusted (OR = 1.55, 95% CI =1.22 -1.98 p < 0.001). The association between
depression and obesity and other possible factors which may influence was more evident
among U. S populations than Europeans p < 0.05 more so for depressive disorder than
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symptoms of depression (p = 0.05). Overweight, however, was associated with
heightened risk of the onset of depression at follow up unadjusted (OR = 1.27; 95% CI =
1.07-1.55 p < 0.01) the findings were statistically significant especially among adults age
20-59 years and adults > 60 years (De Wit et al., 2010).
As previously stated, obesity is a known public health problem. According to
Rush, LeardMann, & Crum-Ciaflone (2016) the prevalence of obesity has increased to
nearly three times the prevalence rate among the national united stated population over
the preceding decades. This figure equated to about 13%- 36% and the consequences are
detrimental. These consequences include poor health outcomes, untimely death,
healthcare costs, loss of productivity and other psychosocial expenses (Rush et al., 2016).
For an individual to enlist in the United States military, standards for weight, height and
body structure is required. As a result, obesity prevalence rates are lower for active duty
personnel than in the general population. Nevertheless, Littman et al. (2013), reported
that weight gain is noted to be relatively higher around 3years before discharge (1.0kg1.3kg/yr.) compared to (0.6kg-0.7kg) while on active duty. Also, an increase of 0.7kg
annually after service period is noted. This trend of weight gain sheds light regarding the
increased rate of weight gain that occurs post deployment.
Summary of Literature review
Although many studies have outlined obesity prevalence, risk factors, and
comorbidities, the impact of depression on health outcomes among veterans. There were
limited cross-sectional studies that described the associated between BMI and depression
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on HBAIC regulation. Through the literature review, it was evident that diabetes,
depression and obesity are prevalent health conditions globally with significant adverse
health outcomes.
For instance, a study by Nelson (2006) utilized data from the 2003 Behavioral
Risk Factor Surveillance System among a national veteran sample of 242,362 to compare
rates of obesity among veterans including veterans who do and do not utilize the VA for
care compared with nonveterans. In this study, the report concluded higher rates of
obesity was present among veterans who used the VA for health services 27.7%
compared to 22.8 for nonveterans. The average age was higher than 60 years with
documented prevalence of DM type II, high blood pressure, high cholesterol, coronary
artery disease, and arthritis. Also, these veterans were more apt to adverse health
outcomes secondary to poor mental and physical health, and poor self-care activities as a
result of the combined health problems.
Cruz-Cano et al. (2015), in a meta-analysis, studied the association between
obesity and depression in patients with diabetes. However, their goal was to understand
whether obesity increases the risk of depression among patients with the diagnosis of DM
type II. Similarly, Lustman and Clouse (2005) conducted a review from multiple
prospective and cross-sectional studies to understand depression in patients with diabetes
and how it correlates with mood and diabetic control. In the synthesis and findings, the
authors concluded concomitant depression is linked with poor glycemic control,
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medication noncompliance, poor dietary habits, poorer quality of life, and increase
healthcare costs.
In this study I add to the body of literature by examining the association between
BMI and depression to understand whether the association predicts poor glycemic control
among veteran’s using secondary data analysis from the VA. The results will inform
providers at the VA with the knowledge that can enhance the development and
implementation of joint forces between mental health and primary care providers. Also, it
will improve preventative interventions and clinical indicators to strengthen AIC
regulations.
This dissertation was quantitative with cross-sectional study design. The principal
method of data collection was by review of electronic medical record and secondary data
analysis from a previous study conducted by the VA research department. A sample of 89
veterans was randomly selected from a secondary database of an earlier study which
consisted of adult veteran’s with DM type II age 18 years to 99 years. Once the
participants were selected the electronic medical record was reviewed for further
variables. In section 2, the research design, methodology, data collection, results, findings
and conclusions will be further discussed.
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Section 2: Research Design and Data Collection
Introduction
In this section, I will outline the research methods used in this study to understand
the association between BMI and depression through a secondary data analysis. Using a
cross-sectional design, I aimed to determine the association between BMI and depression
and to examine whether the association predicts HBA1C control among veterans. This
chapter will include a discussion of the sample, data collection methods, and protection
of participants.
I developed the following research questions and hypotheses to guide this study:
RQ1: Is there an association between BMI and depression among
veterans?
H01: There is no association between BMI and depression
H11: There is an association between BMI and depression.
RQ2: Does the interaction between BMI and depression predict HBA1C
regulation among veterans?
H02: The interaction between BMI and depression does not predict
HBA1C regulation among veterans.
H12: The interaction between BMI and depression does predict HBA1C
regulation among veterans.
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Table, 2.
Research Questions, Variables, Variable Type, and Method of Analyses
_______________________________________________________________________
Research Questions

Variables

Type of Variable

Analyses

________________________________________________________________________
Is there an

BMI

Continuous (Ratio)

Linear

association between

Depression (PHQ-2 SCORE) Categorical (Ordinal) Regression

BMI and depression
Among Veteran’s?
Does the interaction

BMI

Continuous (Ratio)

Multiple

Between BMI and

Depression (PHQ-2 SCORE)

Categorical (Ordinal) Regression

depression predict

Glycemic level (HBA1C)

Continuous (Ratio)

HBAIC regulation?
_______________________________________________________________________

Power and Sample Size
Power and sample size were both relevant to examining the association between
depression and BMI in this study. According to Goldstein (2002), when plotting
statistical power, the investigator should test an experiment with either power of 80% or
90%. To determine the sample for this study, I performed an a priori calculation with G
Power 3.1.9.2, a statistical software used to calculate statistical power and to determine
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effect size (Faul, Erdfelder, Lang, & Buchner, (2007). Using regression with a total of
five predictors, an alpha level of 0.05, a power level of 0.90, and a medium effect size of
0.2, the power analysis estimated that I required a sample size of 89 to reach a power
level of 0.90 in this study.
Table, 3
A Priori Power Analyses
__________________________________________________________________
F tests - Linear multiple regression: Fixed model, R² increase
Analysis:

A priori: Compute required sample size

Input: Effect size f² =

0.20

α err prob

0.05

=

Power (1-β err prob) =

0.90

Number of tested predictors =

5

Total number of predictors

5

Output:

=

Noncentrality parameter λ

Critical F

=

=

17.8000000

2.3244732

Numerator df =

5

Denominator df =

83

Total sample size =

89

Actual power =

0.9036951

________________________________________________________________________
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Protection of Human Subjects and Participant Information
The protection of human subjects is of utmost importance to every study. In this
study, I guaranteed participants anonymity, confidentiality, and security of data through
the omission of personal identifiers per the Health Insurance Portability and
Accountability Act of 1996 (HIPAA). HIPAA and informant consent waivers were
completed to the standards of the VA institutional review board (IRB) requirements to
ensure compliance. I replaced personal identifiers for patients with a unique random
study identifier in the excel dataset for analysis. All data were stored in a secured folder
created by the VA IRB and on a secured VA network, ensuring that the only person that
had access was me, the principal investigator.
I used retrospective data in this study; therefore, no interventions were made. The
only likely risk was the potential loss of confidentiality as a result of the research. If a
breach of privacy had been detected, to protect participants I would have notified the
privacy officer of the VA immediately. Guidelines were followed as directed, such as
those concerning contact with patients, documenting breach of confidentiality in a secure
and locked area, and informing the IRB of Walden University.
Research Design and Strategy
The critical method of data collection in this study was through secondary data
analysis. Public health has historically gathered data that has contributed significantly to
surveillance activity and longitudinal survey research; nonetheless, it is costly to collect
this type of data through primary research (California Department of Public health,
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2016). The availability of electronic health record information made it possible to gather
compressed data in the least expensive way using secondary data analysis.
The data I used to accomplish my research goals in this study were made
available from a previous Health Research Studies and Implementation Projects funded
research. That research was conducted at the VA using a randomized controlled trial of
an intervention modeled to increase veterans’ active participatory communication
patterns, after-visit ranking of self-efficacy to communicate, medication compliance, and
diabetic control (HBA1C). The study title was “Randomized Trial of an Educational
Intervention in DM type II Patients. Protocol Number 12–32.” The Health Research
Studies and Implementation Project collected data on a diverse group of the veteran
population living in Illinois, and the data contained patient demographics and/or
characteristics, such as age, gender, race/ethnicity, HBAIC, lab values, vital signs, and
medical diagnosis.
Protection of Participant rights
All information was de-identified per the IRB and HIPAA privacy guidelines of
the VA. Pertinent patient data remain secured at the research department of the VA. The
total data collection process and analysis took about 3 months. I created an Excel
spreadsheet was created for the data collection. The variables of interest were age, sex,
BMI, weight, Patient Health Questionare-2(PHQ-2) score, and HBA1C level. In this
study, I used existing information in the medical chart to evaluate the association between
BMI and depression.
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One of the risks that I thought would be likely to this process was the potential
loss of confidentiality as a result of the research. However, the risk was decreased by my
use of a limited secondary data set of about 147 participants. All data from this study
were secured in a password-protected VHA server to ensure that only I had access to the
data. Personal identifiers for participants were replaced with a unique, random study
identifier in all analytic data sets. I created a key to link social security numbers of the
sample to the unique random study identifiers I used for the study in the event that study
data must be compared to source data to resolve inconsistencies. The key was passwordprotected and stored on the secure VHA server, ensuring that I, the only principal
investigator personnel have access to the data.
Setting and Sample
The study sample was comprised of a diverse group of a veteran population living
in Illinois who used the VA facility in an urban area. I requested a waiver of consent to
conduct a chart review and obtained the data necessary for the study through the IRB.
The waiver of consent was obtained because the selection of subjects was from a
database of previous research. As a result, it was impossible for me to locate each subject
and have that individual go to a facility to sign a consent form. The financial burden and
time dedicated to seeking a consent form from every veteran whose record would be
examined would have limited the study sample size, which in turn would have limited
generalizability of the review; hence, my use of the request of the waiver. There was a
total of 88 participants with 79 (86.4%) identifying as male and 12 (13.6%) identifying as
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female. The average weight of the participants was 233.8 (SD = 49.456) with a minimum
weight of 161.0 and a maximum weight of 492.0 for a weight range of 330.4 pounds. The
average HBA1C was 9.601 with a minimum score of 6.8 and a maximum score of 13.3
for a range of 6.5. The average BMI was 35.2 with a minimum score of 29.04 and a
maximum score of 79.40 for a range of 50.35. There were 29 participants (32.2%) who
had a major depressive disorder and 61 (67.8%) who did not. There were 44 (50.0%)
Vietnam Era veterans followed by 28 (31.2%) Post-Vietnam, 12 (13.6%) Persian Gulf
War, and four (4.6%) Post-Korean participants. See table 4 for demographic
characteristics of the sample.
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Table 4.
Demographic Characteristics of the Sample
Demographic
Age

Level

Frequency (%)

35-44
45-54
55-64
65-74

1 (1.1%)
11 (12.4%)
36 (40.4%)
41 (46.1%)

Male
Female

78 (87.6%)
11 (12.4%)

White
Black
Other

9 (10.1%)
75 (84.3%)
5 (5.6%)

Below 35
Above 35

60 (67.4%)
29 (32.6%)

Post-Korean War
Vietnam
Post-Vietnam
Persian Gulf War

2 (2.2%)
45 (50.6%)
30 (33.7%)
12 (13.5%)

Married
Divorced
Separated
Widowed
Never Married

39 (43.8%)
23 (25.8%)
4 (4.5%)
3 (3.4%)
20 (22.5%)

Yes
No

75 (84.3%)
14 (15.7%)

Gender

Race

BMI

Era of Service

Marital Status

Primary Care

The study inclusion criteria for the study were veteran, 18yrs – 99 yrs. old, diagnosis of
diabetes, HBAIC > 7.5mg/dl. PHQ-2 score, and BMI. Exclusion criteria: Diabetes type 1,
diagnosis of schizophrenia
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Data Analysis
Statistical Package for the Social Sciences (SPSS) Version 22 (Armonk, NY: IBM
Corporation (2017) was used for data analysis. Statistical significance was assumed at an
alpha value of (p, 0.05). The data in Excel spreadsheet had unique patient identifiers
collected at the VA site. The unique patient identifications were generated to protect
participants.
Statistical Methods
The assumption of normality for continuous variables was assessed with skewness
and kurtosis statistics. If either statistic was above an absolute value of 2.0, then the
distribution was assumed to be non-normal. Mann-Whitney U was used for betweensubjects comparisons when the assumption was violated. Medians and interquartile
ranges (IQR) were reported for these tests. Multiple regression was used to test the
multivariate associations between age, BMI, gender, primary care affiliation, period of
service, marital status, and ethnicity. Linearity, normality, and homoscedasticity were
assessed using normal probability plots and residual analysis. Durbin-Watson statistics
were used to test for autocorrelations and variance inflation factor (VIF) was used to
check for multicollinearity. Change in shared variance and beta values were reported for
the regression model. All analyses were conducted in SPSS Version 22 (Armonk, NY:
IBM Corporation (2017) and statistical significance was assumed at an alpha value of
0.05. In section 3 of this study, I will further discuss the statistical results and
recommendations.
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Section 3: Presentation of the Results and Findings
Introduction
In this study, I aimed to examine the association between BMI and depression and
to test whether this association had an impact on a veteran’s ability to control diabetes as
evidenced by the HBAIC lab value. This evaluation was conducted by reviewing
documented BMI, depressive symptoms, and the HBA1C level as recorded in the
veterans’ computerized medical records. This third section chapter will discuss results
and findings of the study.
Results of Research Question 1
With Research Question 1, I asked: Is there an association between BMI and depression
see table 5 for descriptives.
Table, 5.
Descriptive Statistics
N

M

SD

Statistic

Statistic

Statistic

BMI

88

Valid N

88

(listwise)

35.315

7.3850

Skewness
Statistic

3.165

Kurtosis

STD.

Statistic

Error

Error

.257

14.388

STD

.508
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BMI was not normally distributed per skewness and kurtosis statistics. I used a
nonparametric Mann-Whitney U test to compare the no depression vs. depression groups.
(Mann-Whitney (U) = 774.000, Wilcoxon (W) = 2544.00 Z = -.723, 2-tailed p value
0.469). There was a no significant difference in BMI between the no depression and
depression groups with (p = 0.47. BMI; depressed M= 32.761 IQR = 7.8) BMI; Non
depressed groups (M = 33.274, IQR = 5.0).
Results of Research Question 2
Research Question 2 was: Does the interaction between BMI and depression predict
HBAIC regulation among veterans? In the first model, I used multiple regression to
analyze whether BMI and no depression versus depression predicted for HBA1C
regulation. See table 6 below for the model summary?
Table, 6.
Beta coefficients to analyze the interaction between depression vs.. No depression groups

Unstandardized Coefficients Standardized
Coefficients
B
Std. Error
Beta

Collinearity Statistics
Tolerance
VIF

Model

1

(Constant)
Depressed
BMI

BMIDepressioninteraction

10.483
-.210
-.031
.017

1.556
1.756
.044
.049

t
6.736
-.072 -.120
-.168 -.710
.233 -348

Sig.
.000
.905
.480
.729

.032
.209
.028

31.144
4.787
35.213
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In the table, the beta coefficients show that depression was not predictive of
HBA1C, (p = 0.905, nor was BMI, p = 0.48). The association between the two (an
interaction term) was also not significant, (p = 0.73). Second in the regression model, I
entered BMI, an interaction term for depression*BMI, age, gender, race, era of service,
marital status, and primary care status

Table, 7.
Regression Coefficients
B (SE)

Β

p-value

Constant

12.27 (2.10)

-

< 0.001

Age

-0.04 (0.03)

-0.22

0.19

BMI

-0.02 (0.02)

-0.10

0.41

Depression

-0.12 (0.61)

-0.03

0.77

Gender

-0.10 (0.51)

-0.02

0.85

Primary Care

0.39 (0.46)

0.10

0.40

White

1.19 (0.87)

0.25

0.18

Black

0.89 (0.70)

0.22

0.21

Married

0.07 (0.43)

0.02

0.88

Divorced

0.03 (0.48)

0.01

0.96

Separated

-0.94 (0.82)

-0.13

0.26

Widowed

-1.24 (0.93)

-0.15

0.19

Post-Korean War

-0.55 (1.33)

-0.06

0.68

Vietnam War

-0.14 (0.62)

-0.05

0.82

Post-Vietnam War

-0.28 (0.52)

-0.09

0.60

Depression*BMI

-0.02 (0.01)

-0.22

0.07

Independent Variables

Note: B (SE) – Unstandardized beta coefficient (Standard error), β – Standardized beta
coefficient
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The variables did not account for a significant increase in shared variance in HBA1C
(ΔR2 = 0.17, F (14,74) = 0.17, p = 0.37).

Figure 1.
Histogram displays test for the assumption of normality
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Figure 2.
Test for linearity
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Figure 3.
Scatter plot, test for homoscedasticity.
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Summary
I tested the two hypotheses for the association between depression and BMI on
HBA1C control. The association between BMI and depression were addressed in
Research Question 1, and the results revealed no association between BMI and
depression, (R = 0.02, p = 0.46). The results for Research Question 2 revealed the
association between BMI and depression was not predictive of HBA1C among veterans
(ΔR2 = 0.03, F (2, 84) = 0.80, p = 0.50). I collected the six socio-demographic variables
of marital status, primary care affiliation, service era, race, age, and gender to analyze
their influence on HBA1C control; however, according to the regression analysis, they
were not predictors of HBA1C regulation. There was not a significant increase in
significant increase in shared variance in A1C, ΔR2 = 0.17, F (14, 74) = 0.17, p = 0.37.
There was no significant interaction observed between the variables of marital status,
race, era of service, age, gender, and primary care affiliation on HBA1C regulation.
Due to violations of normality, I assessed the association between depression and
BMI in a nonparametric fashion. For Research Question 1, there was a not a statistically
significant difference between those who were depressed (Mdn = 32.76, IQR = 7.8) and
those who were not depressed (Mdn = 33.27, IQR = 5.0) in terms of BMI, (U = 774.0, p =
0.47). Assumptions for the regression model were met per residual analysis, normal
probability plots, Durbin-Watson statistics, and variance inflation factor (VIF). When the
predictor variables were entered into the regression model to answer research question 2,
they did not account for a significant increase in shared variance in HBA1C (ΔR2 =
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0.17, F(14,74) = 0.17, p = 0.37). In section 4 of this study, I discussed these the overall
impact of chronic disease on population health, I drew in findings from other publications
relevant to my dissertation. In addition, I also discuss the overall impact of obesity,
diabetes and depression on veteran’s health and I make recommendation for social
change and urge primary care and mental health providers to provide seamless health
care for the nation’s veterans.
Section 4: Application to Professional Practice and Implications for Social Change
Introduction
Chronic diseases exert an enormous cost on the U.S. economy. Seeman, Merkin,
Crimins & Karamangla (2010), publicized findings from a NHANES cross-sectional
survey on diabetes prevalence between the years 1988–1994 and 1999–2012. Based on
their findings from NHANES the authors reported that the increased rates of DM type II
results from a combination of an aging U.S population, obesity, physical inactivity, and
genetic factors. They also concluded high unadjusted prevalence rates of diabetes among
persons 65 years and older.
In the United States, an estimated 133 million people are plagued with more than
one chronic condition including diabetes, high blood pressure, and/or respiratory
disorders. The projected amount of the population with chronic conditions are expected
to grow to 157 million by the year 2020 (Raghupathi W & Raghupathi V, 2018).
However, U. S. veterans often suffer many other chronic diseases that include at least one
mental health disorder (Agarwal, 2005). In Illinois, the veteran population over the age
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65 totals 348,000 out of a total veteran population of 722,000 (U.S. Department of VA,
2015). The VA is known to possess one of the largest integrated healthcare organizations
in the United States where over 3 million veterans seek health care annually (U.S.
Department of VA, 2015). Veterans are recognized to be a unique population, based on
their military and or combat experiences; therefore, the VA offers comprehensive health
care benefits to meet the needs of the veterans (Yu et al., 2003).
As of the year 2017, the VA (2018) reported the veteran population to be 19.9
million, of which 9.05 million were enrolled in the VA health system in 2016. In that
same year 2016, there were also 6.26 million unique patients that received treatment
(2018). The VHA has reported the substantial burden of chronic illness among veterans
and supports efforts that target the prevention and reduction of chronic diseases (US
Department of VA, 2018). Based on the strategic goals set forth by the VA secretary,
there is the need to improve the timeliness of the care delivered to veterans and veterans
deserve lifelong integrated care that supports and stresses their wellbeing and
independence (U.S. Department of VA, 2018).
This strategic goal aligns with the vision of Healthy People 2020 with a focus to
provide high-quality care and ensure long lives without disability and diseases from
preventable causes (U.S. Department of Health and Human Services, 2010). The results
of this study will augment what has been previously conducted and published in the area
of diabetes, depression, and chronic health management. In the SCT, Bandura (1986)
stated that social environments and past experiences influence whether a person will
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engage in a specific behavior; however, for this study, I assumed that individuals who are
depressed would unlikely participate in prescribed activities to improve their health.
Interpretation
Many research studies have perfected our understanding of BMI and depression;
however, no one had reported the impact of the association of those variables on HBA1C
regulation. Although Konttinen et al. (2014) focused the association between depressive
symptoms and BMI in a 20-year longitudinal study, the researchers reported that men
tend to have a rapid growth in BMI when they have higher depressive symptoms versus
women. These findings were consistent with a meta-analysis by Wardle, Gibson,
Whitaker, and Steptoe (2011), who reported significant life events and episodes of acute
stress have a substantial impact on obesity prodrome, more so among men than among
women. In a population-based study among the Finnish, Konttinen, Sarlio-Lahteenkorva,
Mannisto, and Haukkala (2010) reported a positive correlation between depressive
symptoms and fat indicators were secondary to emotional eating and individual instinct
on physical activity.
In this study, I selected a sample of 88 diabetic veterans from a VA hospital by
use of secondary data. Among the sample, 33% were depressed, and 67% were not
depressed. First, I aimed to understand the association between BMI and depression;
however, my data analysis revealed no association between BMI and depression (Mdn =
32.76, IQR = 7.8) and those who were not depressed (Mdn = 33.27, IQR = 5.0) in terms
of BMI, (U = 774.0, p = 0.47). This variance potentially arose from the fact that 42% of
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the sample selected was 65 years old and higher, and the VA report only 11% of veterans
age 65 years and older meet the diagnosis of depression.
Second, I aimed to establish whether the association between BMI and depression
were predictive of HBA1C regulation among veterans. When the six predictor variables
were entered into the regression model to answer Research Question 2, For Research
Question 2, when depression, BMI, an interaction term for depression*BMI, age, gender,
race, era of service, marital status, and primary care status were entered into the
regression model, they did not account for a significant increase in shared variance in
A1C,( ΔR2 = 0.17, F(14,74) = 0.17, p = 0.37).The VA and numerous other researchers
have publicized depression as a common condition among veterans. In a longitudinal
study of the effects of depression on A1C control among 11,555 veterans with DM II,
Richardson, Egede, Mueller, Echols, and Gebregziabher (2008) reported that over time
HBA1C levels were significantly higher among depressed veterans versus non depressed
veterans. The mean age of the veterans in their study was 66 years with a follow-up
period of 4.1 years. They concluded that depression drives higher HBA1C levels over
time, confirming a longitudinal relationship (Richardson et al., 2008).
In fact, the VA healthcare system has reported about 25% of the veteran
population who are seen within the healthcare system have diabetes (VA, 2016). A
significant amount of veterans are also known to suffer from chronic pain, substance
abuse, and mental illness which limits their ability to engage in physically active lifestyle
(Holz et al., 2014). Understanding what drives HBA1C regulation beyond obesity and

49
depression may be complex because the health risks and concerns of veterans vary based
on the country of deployment (VA, 2016). For instance, during the Vietnam War, there
were concerns of Agent Orange exposure, a tactical herbicide sprayed by the U.S.
military on trees and other vegetation (VA, 2016).
Sang-Wook, Jae-Seok, Heechoul, and Jee-Jeon (2014) reported that among
Vietnam war veterans, Agent Orange exposure is linked to the prevalence of thyroid and
pituitary gland disorders. The younger cohort of Iraqi and Afghanistan veterans were also
exposed to various environmental and chemical hazards that bore specific health risks
(US Department of VA, 2018). Binge eating has also been associated with
Iraq/Afghanistan veterans who exhibit post-traumatic stress disorder and depressive
symptoms, leading to disproportionate rates of obesity observed among this group of
veterans. In this study, I used a small sample of veterans and a cross-sectional design and
did not explore the cause and effect of other characteristics that may drive poor glycemic
control besides depression and obesity.
Recommendations
As I previously discussed, effective glycemic control, as evident by a low HBA1C
score, produces less diabetic-related complications and improves quality of life, while
poor glycemic control will result in a higher HBA1C score which creates a reduced
quality of life and diabetic-related complications such as cardiovascular, microvascular
and macrovascular diseases ((Zaccardi et al.). Among persons with diabetes, 30% are
known to be concurrently depressed. When a person suffers from depression and diabetes
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simultaneously, complications are heightened, healthcare cost increased, frequent
healthcare utilization, leading to poor outcomes (Richardson et al., 2008).
The results of this study as well as those of other literature on diabetes,
depression, and obesity indicate that the combination of these three issues is a public
health problem that warrants attention and should drive our focus to primary intervention
modalities. My review of extant research confirmed that prediabetes is a risk factor for
diabetes development, which happens insidiously over approximately 4 years in 23% of
the prediabetes population (Hillmer et al 2017). Interventions that address lifestyle
changes such moderate physical activity, balanced diet, and healthy weight loss can delay
prediabetes turning into diabetes (Hillmer et al., 2017). In conjunction, obesity is a
complex issue with no single solution that requires a collaborative approach from the
community, state, business community, healthcare professionals, and schools to chime in
and devote resources to curtail the epidemic. The golden standard for solving the obesity
epidemic is healthy eating habits and frequent physical activities (CDC, 2017).
Depression is a common mental health disorder that can co-occur with medical illnesses,
such as diabetes, and it is characterized by low mood and irritability (National Institute of
Mental Health (NIMH), 2018) however, no matter how severe the depression may be, it
can be treated with medication and or psychotherapy (NIMH, 2018). The key to
managing symptoms is medication and treatment compliance in addition to physical
activity (NIMH, 2018). Physical activity will help counteract weight again; the side
effects of antidepressants and improve the overall mood of the individual (NIH, 2018).
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Several factors affect an individual’s social and health wellbeing, such as
socioeconomic environment, dietary pattern, physical environment, family, cultural and
social beliefs, trade, economics, and policies (Kumar & Preetha, 2012). As humans
continue to develop an understanding of the factors that affect health and social wellbeing, health issues have to be addressed holistically. Creating the means to empower
individuals and empower communities to take control of their health and foster public
health leadership can work collaboratively to build effective public health policies in all
avenues and create long-lasting healthcare systems (Kumar & Preetha, 2012).
Implications for Future Research
In this study, I focused on the veteran population in an urban area of Illinois. The
results from this study may be generalized to a national community of veterans who have
similar backgrounds of military and combat experience. I also looked at depressive
symptoms reported over a three-month period versus actual diagnosis of depression per
International Classification of Diseases Tenth Revision, Clinical Modification (ICD-10CM). Although war era was not the focus of this study, prior research has found that
many illnesses stem from environmental exposure suffered during combat (Mclean And
Edwards, 2016). Veterans have unique experiences compared to the average nonveteran
and stand at risk for poorer health with mental illnesses being a top priority area of
concern (Maclean & Edwards, 2016). Although the researchers did not find an
association between BMI and depression, Richardson et al. (2008) confirmed a
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longitudinal relationship between the variables, therefore showing that over time,
depression can contribute to higher HBA1C levels among veterans.
HBA1C is known to be the key indicator of glycemic control over a period of 2–
3 months and also informs the clinician of the risk of diabetic-related complications.
Higher A1C levels put an individual at risk for stroke and cardiovascular disease
(Sherwani, Khan, Ekhzaimy, Massod, & Sakharkar, 2016). Based on this knowledge,
clinicians can continue to educate veterans regarding the clinical risks of poor glycemic
control. Depressive symptoms have been reported higher among persons with diabetes
and can produce poor blood sugar levels (Sherwani et al, 2016). Therefore, it is important
for clinicians to join efforts with mental health providers while caring for veterans.
Further research is warranted for a national study of the veteran population and
consideration should be made for veterans who are being treated for depression compared
to those who do not receive treatment. Other factors worth exploring are the impact of
socioeconomic status and homelessness on the management of chronic diseases.
Social Change Implications
Despite the numerous publications regarding obesity, diabetes, and depression
which affect the population, there are still many strides needed to achieve a society free
of chronic illness. This study shed light on the many complications that affect an
individual when they are faced with multiple comorbidities and can aid the veterans’
health administration to beef up resources and programs that target veterans who met
with this health challenge. There is the opportunity to focus on how clinicians can work
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collectively together within primary care setting to ensure resources and referrals are
seamless upon initial contact with the veteran. The study results can add to the current
body of literature about diabetes, obesity, depression and veteran’s health.
Also, it contributes to relevant information to the research which supports that
depression can produce ineffective glycemic control. That the rates of obesity are on the
rise because of physical inactivity and poor HBA1C leads to poor health outcomes.
Results of this study will be disclosed to decision makers of the VA medical center where
the study was conducted. This will provide the opportunity for programs to be reviewed
and resources allotted to areas that can be beneficial. As previously stated, chronic
diseases exert an enormous cost to the economy. To prevent these diseases can be
achieved by modifying risk factors. Otherwise, if left untreated, it can lead to severe
complications leading to disability and death. Looking at the characteristics of veterans
and the many chronic conditions, clinicians need to focus on disease-specific
interventions on enhancing well-being.
Conclusions
Multiple chronic conditions demand to routine and multifaceted care
management. When an individual harbors numerous chronic conditions it promotes
reduced quality of life and function and mortality, and morbidity are both increased. The
high prevalence of chronic conditions can increase health care costs, morbidity, and
mortality. The veterans’ health care administration reports a high burden of multiple
chronic diseases compared to the general population among veterans. To improve the
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quality of chronic care does require an expansive understanding of the mental health
issues facing the veterans order to provide improvement modalities.
The study has outlined significant multiple health indicators and avenues for
prevention. However, it is imperative to understand the importance of including the
veteran as a partner to wellness when structuring interventions. Most importantly
providers need to pay close attention to depressive symptoms as this will trigger early
detection to initiate timely treatment.
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